Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin-Reference-Cited by-同舟云学术

Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin

Published:2024-03 Issue:3 Volume:30 Page:312.e1-312.e7
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

El Fakih Riad^ORCID,Nassani Momen,Rasheed Walid^ORCID,Hanbali Amr,Almohareb Fahad,Chaudhri Naeem^ORCID,Alsharif Fahad,Alfraih Feras,Shaheen Marwan^ORCID,Alhayli Saud,Alkhaldi Hanan,Alshaibani Alfadel,Alotaibi Ahmad S.,Alahmari Ali,Alamer Abdullah^ORCID,Tarig Abrar,Youniss Riad^ORCID,Albabtain Abdulwahab A.,Alfayez Mansour,Saad Ayman^ORCID,Ahmed Syed Osman,Alzahrani Hazzaa,Aljurf Mahmoud

Publisher

Elsevier BV

Reference30 articles.

1. “No donor”? Consider a haploidentical transplant;Ciurea;Blood Rev,2015

2. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide;O'Donnell;Biol Blood Marrow Transplant,2002

3. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation;Bashey;J Clin Oncol,2013

4. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts;Raiola;Biol Blood Marrow Transplant,2014

5. Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignancies following a myeloablative conditioning: an update;Bacigalupo;Bone Marrow Transplant,2015